BRAF and colorectal carcinoma: The results demonstrated a greater frequency of KRT7 expression in BRAF-mutated MSS CRC (39%) when compared with BRAF-mutated MSI CRC (6%) or BRAF wild-type MSS CRC (6%) (17).